International Programs News, Speeches, and Publications
Image
Connect with us: Follow @FDA_Global on Twitter
FDA International News
- FDA Expands Mutual Recognition Agreement with European Union, OGPS Statement, May 31, 2023
- Japanese Officials Meet with FDA to Discuss Future Collaborations, OGPS Statement, May 9, 2023
- Xinjiang Uyghur Autonomous Region of the People's Republic China, OGPS Statement, April 12, 2023
- FDA Officials Meet with Delegation from Nigeria, OGPS Statement, April 4, 2023
- FDA Officials Meet with Representatives of Mexico’s National Service of Agro-Alimentary Health, Safety and Quality (SENASICA), OGPS Statement, March 28, 2023 [Spanish translation]
- South Korean Health Officials Meet with FDA to Discuss Future Collaborations, OGPS Statement, March 21, 2023
- Danish Minister of Health and Danish Medicines Agency Meet with FDA to Discuss Future Collaborations, OGPS Statement, March 10, 2023
- FDA Agreement on Mutual Recognition between the Swiss Confederation and the United States of America Relating to Pharmaceutical Good Manufacturing Practice, OGPS Statement, January 12, 2023
- OGPS Leadership Message on Local Employed Staff Appreciation Day, OGPS Statement, November 16, 2022
- FDA Signs Confidentiality Commitment with Ecuador, OGPS Statement, August 18, 2022 [Spanish translation]
- FDA Meets with European Food and Drug Regulators, OGPS Statement, July 8, 2022
- Brazilian Health Regulatory Agency Meets with FDA to Discuss Medical Product Issues, OGPS Statement, May 18, 2022
- Meeting of Officials of the U.S. Food and Drug Administration and the German Federal Institute for Risk Assessment, OGPS Statement, May 9, 2022
U.S. Government Documents of International Interest
- Joint Update by the Department of State and the Department of Health and Human Services on Negotiations Toward a Pandemic Accord
- Letter Exchange Involving Aspartame
International Partner News
- Reducing shortage of nurses key to better respond to the next pandemic, Pan American Health Organization, Press Release, May 2023
- Germany provides first of a series of donations to the Fisheries Fund and offers expertise, World Trade Organization, Press Release, May 2023
- EMA and European medicines regulatory network lift COVID-19 business continuity status, European Medicines Agency, Press Release, May 2023
- Asia Pacific Business Leaders Call for Forging a New Path on Inclusion, Resilience, and Sustainability, Asia-Pacific Economic Cooperation, Press Release, May 2023
- PAHO calls on local governments to join initiatives to promote healthy cities and communities, Pan American Health Organization, Press Release, April 2023
- Global Announce a New Effort – “The Big Catch-up” – to Vaccinate Millions of Children and Restore Immunization Progress Lost During the Pandemic, Gates Foundation, Press Release, April 2023
- Canada commits CAD700,000 to strengthen developing countries’ food safety systems, World Trade Organization, Press Release, April 2023
- First vaccine to protect older adults from respiratory syncytial virus (RSV) infection, European Medicines Agency, Press Release, April 2023
Speeches
- Remarks by Associate Commissioner Mark Abdoo at the International Bar Association World Life Sciences Conference, June 1, 2023
- Remarks by Associate Commissioner Mark Abdoo at the Food & Drug Law Institute 2023 Conference, May 18, 2023
- Remarks by Associate Commissioner Mark Abdoo at the Asia-Pacific Economic Cooperation Medical Product Supply Chain Dialogue, April 25, 2023
- Remarks by Associate Commissioner Mark Abdoo at the Indian Society for Clinical Research 16th Annual Meeting, February 24, 2023
- Remarks by Associate Commissioner Mark Abdoo at the Parenteral Drug Association India Chapter 10th Annual Meeting, February 21, 2023
Publications
Blog
- From a Global Perspective - Occasional thought pieces on international topics from FDA experts across the agency
Newsletter
- Global Update – Global news, information, events, and resources from the FDA Office of Global Policy and Strategy
FDA Voices
- Using A Whole-Of-Governments Approach to Combating Illicit Health Products, FDA Voices, September 1, 2022
- Global Regulators Envision Paradigm Shift Toward Inclusion of Pregnant and Breastfeeding Women in Clinical Research for Medicines and Vaccines, FDA Voices, July 19, 2021
- FDA’s Partnership with Mexico’s Regulators Strengthens Food Safety Protections, FDA Voices, March 17, 2021
- Equivalence: Using a Trade Mechanism to Ensure Broader Consumer Choice and Open New Markets for Molluscan Shellfish, FDA Voices, September 23, 2020
- Ensuring Patient Safety and Drug Manufacturing Quality Through Partnership with European Union Regulators, FDA Voices, by Anna Abram, FDA Deputy Commissioner for Policy, Planning, Legislation and Analysis and Mark Abdoo, FDA’s Associate Commissioner for the Office of Global Policy and Strategy, FDA Voices, July 11, 2019
- FDA’s Global Efforts to Protect Patients and Consumers from Unsafe Products, FDA Voices, by Anna Abram, FDA Deputy Commissioner for Policy, Planning, Legislation and Analysis and Mark Abdoo, FDA’s Associate Commissioner for the Office of Global Policy and Strategy, FDA Voices, November 29, 2018
- FDA Collaborates to Promote Safety, Quality in Clinical Trials Done in India, FDA Voices, July 12, 2017
- FDA in India: Championing a Culture of Quality, FDA Voices, March 28, 2017